Showing results (91-100 of 162) with videos related to

Sort By:
Pageof 17
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care|April 20, 2018
Future unrelated medical costs need to be considered in cost effectiveness analysisPieter van Baal, Alec Morton, David Meltzer, et al.
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care|July 30, 2025
Nothing about us, without us? A reflection on and call for involving children in the process of valuing child healthAva Hoogenboom, Vivian Reckers-Droog, Stefan Lipman, et al.
Social Science & Medicine (1982)|September 26, 2021
Estimating the costs of non-medical consumption in life-years gained for economic evaluationsKlas Kellerborg, Bram Wouterse, Werner Brouwer, et al.
Pharmacoeconomics|March 1, 2023
Production Losses due to Absenteeism and Presenteeism: The Influence of Compensation Mechanisms and Multiplier EffectsWerner Brouwer, Kaya Verbooy, Renske Hoefman, et al.
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care|January 23, 2024
On spillovers in economic evaluations: definition, mapping review and research agendaMaría J Mendoza-Jiménez, Job van Exel, Werner Brouwer
Medical Decision Making : an International Journal of the Society for Medical Decision Making|September 18, 2015
A Framework for Including Family Health Spillovers in Economic EvaluationHareth Al-Janabi, Job van Exel, Werner Brouwer, et al.
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care|September 28, 2022
Willingness to pay for health gains from an international integrated early warning system for infectious disease outbreaksMeg Perry-Duxbury, Sebastian Himmler, Job van Exel, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|October 7, 2009
In or out? Income losses in health state valuations: a reviewCarl Tilling, Marieke Krol, Aki Tsuchiya, et al.
Pharmacoeconomics|August 16, 2005
Societal discounting of health effects in cost-effectiveness analyses: the influence of life expectancySuzanne Polinder, Willem Jan Meerding, Job van Exel, et al.
Medical Decision Making : an International Journal of the Society for Medical Decision Making|November 11, 2015
Altruistic Preferences in Time Tradeoff: Consideration of Effects on Others in Health State ValuationsMarieke Krol, Arthur E Attema, Job van Exel, et al.
Pageof 17